Insulet Corporation
PODD · Healthcare · Health Care
Updated 25 min ago · data delayed ≥15 min
IconicScore
ProprietaryRanked #486 of 500 by Iconic Score · #58 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.
Get the free morning email
The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →
Price performance
Export history · AnalystThis insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.
Upgrade to AnalystThis is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.
Upgrade to EnterpriseIconic Profile
Insulet Corporation (PODD) is a leading medical device company specializing in innovative insulin delivery systems for individuals with diabetes. Its flagship product, the Omnipod Insulin Management System, offers a tubeless, waterproof insulin pump that enhances patient convenience and adherence to therapy. With a market capitalization of $11.3 billion, Insulet has established a strong position within the healthcare sector by focusing on technology-driven solutions that improve the quality of life for diabetes patients. The company's commitment to continuous innovation and expansion into new markets underscores its significance in addressing the growing global diabetes epidemic. As the demand for advanced diabetes management solutions rises, Insulet's role in providing effective and user-friendly products positions it as a key player in the healthcare landscape.
IconicOracleAI™ Brief
Insulet Corp's Iconic Score of 29 reflects challenges in brand perception amid increased competition, particularly from DexCom's recent positive results in diabetes management. Despite a strong brand-visibility signal of 75/100, the company's stock price has seen a slight decline of 0.52%. Recent announcements, such as the launch of the Omnipod Discover in the U.S., aim to enhance market presence but have not significantly shifted overall sentiment.
AI-generated explanation of current score drivers. Not investment advice.
Enterprise tier: claim your logo to manage how your brand is represented.